Q32 Bio Inc.
QTTB
$15.15
-$0.22-1.43%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | 53.74M | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | 53.74M | -- | -- |
| Cost of Revenue | 4.26M | 3.22M | 3.32M | 3.56M | 5.16M |
| Gross Profit | -4.26M | -3.22M | 50.42M | -3.56M | -5.16M |
| SG&A Expenses | 4.86M | 4.50M | 4.54M | 4.02M | 4.01M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 9.12M | 7.72M | 7.86M | 7.58M | 9.17M |
| Operating Income | -9.12M | -7.72M | 45.88M | -7.58M | -9.17M |
| Income Before Tax | -8.95M | -7.61M | 57.73M | -7.39M | -9.49M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -8.95M | -7.61M | 57.73M | -7.39M | -9.49M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -8.95M | -7.61M | 57.73M | -7.39M | -9.49M |
| EBIT | -9.12M | -7.72M | 45.88M | -7.58M | -9.17M |
| EBITDA | -9.03M | -7.63M | 45.97M | -7.49M | -9.08M |
| EPS Basic | -0.44 | -0.54 | 4.60 | -0.60 | -0.78 |
| Normalized Basic EPS | -0.27 | -0.34 | 2.29 | -0.38 | -0.49 |
| EPS Diluted | -0.44 | -0.54 | 4.59 | -0.60 | -0.78 |
| Normalized Diluted EPS | -0.27 | -0.34 | 2.29 | -0.38 | -0.49 |
| Average Basic Shares Outstanding | 20.34M | 14.10M | 12.56M | 12.24M | 12.20M |
| Average Diluted Shares Outstanding | 20.34M | 14.10M | 12.59M | 12.24M | 12.20M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |